- Home
- CRS vs ROIV Comparison
CRS vs ROIV Comparison
Compare CRS & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRS
- ROIV
- Stock Information
- Founded
- CRS 1910
- ROIV 2014
- Country
- CRS United States
- ROIV United Kingdom
- Employees
- CRS N/A
- ROIV N/A
- Industry
- CRS Steel/Iron Ore
- ROIV Biotechnology: Pharmaceutical Preparations
- Sector
- CRS Industrials
- ROIV Health Care
- Exchange
- CRS Nasdaq
- ROIV Nasdaq
- Market Cap
- CRS 9.4B
- ROIV 8.4B
- IPO Year
- CRS N/A
- ROIV N/A
- Fundamental
- Price
- CRS $170.21
- ROIV $10.15
- Analyst Decision
- CRS Buy
- ROIV Buy
- Analyst Count
- CRS 6
- ROIV 4
- Target Price
- CRS $156.33
- ROIV $17.50
- AVG Volume (30 Days)
- CRS 846.0K
- ROIV 8.0M
- Earning Date
- CRS 04-24-2025
- ROIV 05-29-2025
- Dividend Yield
- CRS 0.47%
- ROIV N/A
- EPS Growth
- CRS 84.03
- ROIV N/A
- EPS
- CRS 5.30
- ROIV N/A
- Revenue
- CRS $2,878,100,000.00
- ROIV $122,585,000.00
- Revenue This Year
- CRS $7.55
- ROIV N/A
- Revenue Next Year
- CRS $8.49
- ROIV N/A
- P/E Ratio
- CRS $32.12
- ROIV N/A
- Revenue Growth
- CRS 5.64
- ROIV 140.04
- 52 Week Low
- CRS $74.21
- ROIV $8.73
- 52 Week High
- CRS $213.66
- ROIV $13.06
- Technical
- Relative Strength Index (RSI)
- CRS 45.60
- ROIV 50.07
- Support Level
- CRS $168.84
- ROIV $9.90
- Resistance Level
- CRS $179.49
- ROIV $10.26
- Average True Range (ATR)
- CRS 12.49
- ROIV 0.47
- MACD
- CRS 0.77
- ROIV 0.06
- Stochastic Oscillator
- CRS 63.28
- ROIV 92.81
About CRS Carpenter Technology Corporation
Carpenter Technology Corp supplies specialty metals to a variety of end markets, including aerospace and defense, industrial machinery and consumer durables, medical, and energy, among others. The company's reportable segments include; Specialty Alloys Operations and Performance Engineered Products. It generates maximum revenue from the Specialty Alloys Operations segment. The SAO segment is comprised of the company's alloy and stainless steel manufacturing operations. This includes operations performed at mills predominantly in Reading and Latrobe, Pennsylvania, and surrounding areas as well as South Carolina and Alabama. Geographically, the company derives its maximum revenue from the United States and the rest from Europe, Asia Pacific, Mexico, Canada, and other regions.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.